Arvee Laboratories (India) enterprise value

·UnclassifiedChart ›

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


201	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.4	0.4	0.2	1.9	0.5
1.1	1.1	1.0	1.0	1.0
201	—	—	—	—
0.7	0.7	0.8	−0.9	0.5
₹182.61	—	—	—	—

34.9	34.9	32.3	30.1	29.1
3.2%	3.2%	3.2%	3.3%	3.4%
0.01×	—	—	—	—

4.88×	—	—	—	—
37.61×	—	—	—	—
48.98×	—	—	—	—
41.3	31.5	38.5	30.3	62.5
5.4	3.2	3.6	3.0	8.4
4.1	2.0	2.5	1.5	6.3
—	−0.1	−0.0	6.7	2.4
−3.0	−3.0	−1.9	4.1	0.9
—	−3.0	−2.0	4.0	0.8
—	2.8	1.9	2.6	1.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ARVEE₹182.00

Arvee Laboratories (India) Limited

· Unclassified

₹ CrorePeersSPCENET GVPTECH MCL NITIRAJ ASPINWALLJMA SINTERCOMMcap ₹201 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	200.6
- Cash, Equiv & ST Investments	0.5	1.9	0.2	0.4	0.4
+ Total Debt	1.0	1.0	1.0	1.1	1.1
Enterprise Value	—	—	—	—	201.2
Net Debt (memo)	0.5	-0.9	0.8	0.7	0.7
EV per Share	—	—	—	—	182.61

Total Capital	29.1	30.1	32.3	34.9	34.9
Total Debt/Total Capital	3.44	3.32	3.20	3.19	3.19
Total Debt/EV	—	—	—	—	0.01

EV/Sales	—	—	—	—	4.88
EV/EBITDA	—	—	—	—	37.61
EV/EBIT	—	—	—	—	48.98
Reference Items — Trailing FY Values
Sales	62.5	30.3	38.5	31.5	41.3
EBITDA	8.4	3.0	3.6	3.2	5.4
EBIT	6.3	1.5	2.5	2.0	4.1
Operating Cash Flow	2.4	6.7	-0.0	-0.1	—
Free Cash Flow	0.9	4.1	-1.9	-3.0	-3.0
FCFF (free cash flow to the firm)	0.8	4.0	-2.0	-3.0	—
Capital Expenditure	1.5	2.6	1.9	2.8	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.